Wellnex Life Ltd

As of June 30, 2024, Wellnex Life Ltd carries a market capitalization of 32.24M, placing it among publicly traded companies globally. Its enterprise value stands at 42.00M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Wellnex Life Ltd's next confirmed earnings release is scheduled for March 4, 2027.

As of June 30, 2024, Wellnex Life Ltd has 28.46M shares outstanding.

These figures are as of June 30, 2024. The price-to-sales ratio is 1.26, and the price-to-book ratio stands at 4.49.

These figures are as of June 30, 2024. The EV/Sales ratio of 2.48 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 42.00M versus a market cap of 32.24M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2024, Wellnex Life Ltd maintains a current ratio of 0.35, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 148.52, indicating elevated leverage, while an interest coverage ratio of -4.23 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2024, Wellnex Life Ltd posted a negative return on equity (ROE) of -379.04, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -64.63, reflecting losses generated across the asset base. Inventory turnover of 3.79 indicates how many times Wellnex Life Ltd sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 21, 2026, Wellnex Life Ltd's stock has declined approximately 67.80% over the past 52 weeks. The 50-day moving average sits at 0.08, while the 200-day moving average is 0.09.

Over the twelve months ended June 30, 2024, Wellnex Life Ltd generated 16.93M in revenue and converted that into -14.74M in net income, yielding earnings per share of -0.79. EBITDA reached -10.12M, while operating income came in at -6.45M.

As of June 30, 2024, Wellnex Life Ltd holds 903,000.00 in cash and equivalents against 10.67M in total debt, resulting in a net debt position of 9.71M. Total book value stands at 7.18M, with working capital of -17.85M providing operational flexibility.

Over the twelve months ended June 30, 2024, Wellnex Life Ltd posted a gross margin of 29.96, reflecting its pricing power and cost economics. The operating margin of -38.12 and net profit margin of -87.04 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2024. Total shareholder yield is negative at -64.58, meaning Wellnex Life Ltd raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Wellnex Life Ltd's most recent stock split took place on February 14, 2025 with a 29:32 split ratio.

As of June 30, 2024, Wellnex Life Ltd has an Altman Z-Score of -20.39, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.